Navigation Links
Quanterix Announces Publication of Novel Method Expanding Single Molecule Detection Capability
Date:2/23/2011

s unprecedented assay performance, stemming from a 1,000-fold improvement in sensitivity compared with today's analog only technology. SiMoA will enable researchers in life science to validate novel, low abundance biomolecules from a single droplet of blood, leading to greater insight into disease detection, diagnosis, therapy selection and disease monitoring. Automated systems based on SiMoA will provide diagnostic test information to healthcare practitioners faster, with greater reliability, unprecedented range and increased cost effectiveness.  Founded in 2007, the privately held Cambridge, Massachusetts-based company is backed by leading life science investors including ARCH Venture Partners, Bain Capital Ventures, and Flagship Ventures. For additional information, please visit www.quanterix.com.


'/>"/>
SOURCE Quanterix Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Quanterix Announces New Technology Evaluation Agreement
2. Quanterix Corporation Announces the Addition of Dr. Robert Corn to its Scientific Advisory Board
3. Stereotaxis Announces Election of Joseph D. Keegan to Board of Directors
4. China Cord Blood Corporation Announces Results of 2010 Annual General Meeting
5. Dendreon Announces Presentation of PROVENGE Data at the 2011 Genitourinary Cancers Symposium Annual Meeting
6. Sensus Healthcare Announces Its Exhibitor Attendance at the 9th Annual South Beach Symposium™
7. Sensus Healthcare Announces the Formation of a Medical Advisory Board
8. Sigma-Aldrich Announces Organizational Changes
9. Optimer Pharmaceuticals, Inc. Announces Exercise in Full of Underwriters Option to Purchase Additional Shares and Closing of Public Offering of Common Stock
10. MiMedx Announces Launch of AmnioFix™
11. Savient Pharmaceuticals Announces Executive Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... 30, 2015 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a commercial focus on China , ... (CFDA) has approved the Company,s application to conduct a ... carcinoma (OCCC) patients for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... , March 30, 2015 ... biological drugs to treat cancer, viral infections and ... Sir John Bell , the Regius Professor ... the Office for the Strategic Coordination of Health ... effect.      (Photo: http://photos.prnewswire.com/prnh/20150330/736483 ...
(Date:3/29/2015)... , March 29, 2015  Caris ... study data in small cell cervical cancer ... Caris Molecular Intelligence®, the company,s panomic, comprehensive ... gene mutations which may explain sensitivities and ... that identification of certain biomarkers may guide ...
(Date:3/27/2015)... 2015  Peter Walter wurde als Gewinner ... seine bahnbrechende Arbeit ausgewählt, die sich damit ... sowie für die Entschlüsselung der Komponenten eines ... nutzen, der mit der Ansammlung von deformierten ... Biochemie an der University of California, San ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Immunocore Appoints Professor Sir John Bell to its Board of Directors 2Immunocore Appoints Professor Sir John Bell to its Board of Directors 3Immunocore Appoints Professor Sir John Bell to its Board of Directors 4Immunocore Appoints Professor Sir John Bell to its Board of Directors 5Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 2Study Using Caris Molecular Intelligence Multiplatform Tumor Profiling Identifies Potential Treatment Strategies for Small Cell Cervical Cancer 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 2Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 3Deutschstämmiger Zellbiologe Peter Walter gewinnt den Vilcek Prize in Biomedical Science 2015 4
... 9 Millennium: The Takeda,Oncology Company today announced ... in the world, according to Science magazine,s,annual survey ... related industries. With a 2008 ranking of eighth, ... first time, moving up from a 2007 ranking,of ...
... Join Forces to Deliver Patient Care via Single ... Platform, MirixaPro(SM), ... American Pharmacists Association (APhA) Foundation, the creator of,the Diabetes Ten City ... they will form a new partnership that will,deliver all of APhA ...
... Va., Oct. 9 CEL-SCI Corporation,(NYSE: CVM ... of the new,manufacturing facility for its lead drug ... will produce the Multikine that,will be used for ... of previously untreated head and neck cancer patients, ...
Cached Biology Technology:Millennium Ranks in the Top 10 Best Biopharma Employers in the World by Science Magazine 2Mirixa Corporation and the APhA Foundation Form Partnership 2Mirixa Corporation and the APhA Foundation Form Partnership 3CEL-SCI Takes Delivery of New Manufacturing Facility 2
(Date:3/17/2015)... 2015 Emotient, the leader in facial ... general availability of Emotient Analytics , the ... of facial expressions. The system analyzes videos of ... and services. It delivers audience response metrics - ... as derived from facial evidence of emotional states. ...
(Date:3/12/2015)... March 12, 2015 Beta ... identity and access management (IAM) solution for a ... With Beta System,s new IAM package, customers benefit ... gleaned from multiple IAM implementations across different industries. ... as well as any necessary services and consulting. ...
(Date:3/10/2015)... , March 10, 2015 ... "Personalized Medicine in Human Space Flight" ... Thomas J. Goodwin , Ph.D. was recently featured ... the past two years. Specifically, "Personalized Medicine ... downloaded scientific papers published in 2013 and 2014 from ...
Breaking Biology News(10 mins):New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2"Personalized Medicine in Human Space Flight" Listed Among Most Influential Papers of 2013 and 2014 2
... have good reason for engaging in sexual, rather than ... biology in the UI College of Liberal Arts and ... for Genomics. In an article published in a ... Evolution , she and her colleagues, including John M. ...
... YORK, NY (January 21) - New York Stem Cell Foundation ... is lead author on a study defining conditions for generating ... suitable for therapeutic use. Dr. James and his colleagues ... can be used to measure endothelial cell production and activity. ...
... a surprising finding, researchers at North Carolina State University ... believed to be a redundant "on switch" for certain ... Scientists previously understood that the protein called TAB2 ... and prevents invasion of harmful organisms. But scientists considered ...
Cached Biology News:NYSCF Fellow lead author on study that creates blood vessel cells from stem cells 2Inflammation 'on switch' also serves as 'off switch' 2
... MULTI-FUN Incubator is a compact benchtop ... a microprocessor controller with a large ... and agitation speed. Air circulation inside ... incubator. Temperature can be easily calibrated ...
... The CERTOMAT RM is specifically designed as ... densities. The new variable mass compensation allows ... conditions yielding better aeration and, therefore, faster ... orbital shaker is ideal when high reproducibility ...
... The iCycler thermal cycler with 96 ... for nucleic acid amplification (PCR) applications. It ... module (15-100 microliter samples) that is compatible ... features temperature monitoring and control by algorithm, ...
...
Biology Products: